Records containing: Recurrent Childhood Rhabdomyosarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-14NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
-
CLINICAL_TRIALS study record update · 2025-07-11Adopting a Functional Precision Medicine Approach For Individualized Pediatric Cancer Treatments
-
CLINICAL_TRIALS study record update · 2025-02-10Cardiac-Sparing Whole Lung IMRT in Children and Young Adults With Lung Metastases: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2024-09-19NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Erdafitinib in Patients With Tumors Harboring FGFR1/2/3/4 Alterations
-
CLINICAL_TRIALS study record update · 2024-04-25NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- A Phase 2 Subprotocol of Olaparib in Patients With Tumors Harboring Defects in DNA Damage Repair Genes
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-10-03A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
-
CLINICAL_TRIALS study record update · 2023-09-15Mechanism of Children With Relapsed and Refractory Rhabdomyosarcoma (RMS)
-
CLINICAL_TRIALS study record update · 2023-05-10Personalized Ex Vivo Drug Screening and Genomics Profiling to Guide Individualized Treatments for Children With Relapsed or Refractory Solid Tumors and Leukemias
-
CLINICAL_TRIALS study record update · 2018-08-07A Phase II Study of Imetelstat (GRN163L, NSC# 754228) in Children With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2017-06-05A Phase II Study of MLN8237, a Selective Aurora A Kinase Inhibitor in Children With Recurrent/Refractory Solid Tumors and Leukemias
-
CLINICAL_TRIALS study record update · 2017-05-09A Randomized Double Blinded Trial of Topical Caphosol to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2017-05-05A Randomized Phase II Trial of Bevacizumab (Avastin) and Temsirolimus (Torisel) in Combination With Intravenous Vinorelbine and Cyclophosphamide in Patients With Recurrent/Refractory Rhabdomyosarcoma
-
CLINICAL_TRIALS study record update · 2017-01-20A Pilot Study to Evaluate the Potential Efficacy of Lithium Carbonate for Stimulation of Intestinal Recovery In Patients With Acute Graft-versus-host Disease (GVHD)
-
CLINICAL_TRIALS study record update · 2016-07-14Observational - Identifying and Validating Novel Mechanisms of Radiation Resistance in Rhabdomyosarcoma
-
CLINICAL_TRIALS study record update · 2016-05-18Developmental Pathway Drug-Targets in Advanced Rhabdomyosarcomas
-
CLINICAL_TRIALS study record update · 2016-05-18Tissue Microarray Studies of the 12q13-q14 Amplicon in Alveolar Rhabdomyosarcoma
-
CLINICAL_TRIALS study record update · 2016-05-17A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2015-05-15A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib in Children and Young Adults With Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2015-03-31A Phase II Study of Cixutumumab (IMC-A12) in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-03-30A Phase II Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody, NSC #742460) in Children With Relapsed/Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-11-14Phase II Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Children and Young Adults With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-02-14Soluble Tumor Necrosis Factor Receptor: Enbrel® (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2014-01-27A Phase II Study Of Trabectedin (ET-743, Yondelis®) in Children With Recurrent Rhabdomyosarcoma, Ewing Sarcoma, or Nonrhabdomyosarcomatous Soft Tissue Sarcomas
-
CLINICAL_TRIALS study record update · 2013-07-02A PHASE I STUDY OF FLAVOPIRIDOL (NSC# 649890; IND# 46211) IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC SOLID TUMORS OR LYMPHOMAS
-
CLINICAL_TRIALS study record update · 2013-06-14Phase II Trial of Irinotecan in Children With Refractory Solid Tumors